Ascend Wellness Holdings (AAWH) Interest Expenses (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Interest Expenses of $20.3 million in Q1 2026, up 30.8% quarter-over-quarter from $15.5 million in Q4 2025, and up 80.99% on a YoY basis from $11.2 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Interest Expenses (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Interest Expenses history runs 7 years deep, the most recent figure standing at $20.3 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 80.99% year-over-year to $20.3 million; the TTM figure through Mar 2026 stood at $60.4 million (up 25.97% YoY), while the FY2025 annual figure was $51.3 million, up 13.32% from the prior year.
- Interest Expenses was $20.3 million for Q1 2026 at Ascend Wellness Holdings, up from $15.5 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $20.3 million in Q1 2026 to a low of $6.0 million in Q1 2022.
- Historically, Interest Expenses has averaged $11.0 million across 5 years, with a median of $9.2 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Interest Expenses slumped 74.93% in 2022, then soared 83.88% in 2024.
- A 5-year view of Interest Expenses shows it stood at $8.7 million in 2022, then decreased by 1.83% to $8.6 million in 2023, then jumped by 36.71% to $11.7 million in 2024, then jumped by 32.24% to $15.5 million in 2025, then surged by 30.8% to $20.3 million in 2026.
- The last three Interest Expenses figures came in at $20.3 million (Q1 2026), $15.5 million (Q4 2025), and $12.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4.86 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | 20.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.25 Mn |
| Mar 31, 2026 | 20.25 Mn |
| Dec 31, 2025 | 15.48 Mn |
| Dec 31, 2025 | 15.48 Mn |
| Sep 30, 2025 | 12.56 Mn |
| Sep 30, 2025 | 12.56 Mn |
| Jun 30, 2025 | 12.06 Mn |
| Jun 30, 2025 | 12.06 Mn |
| Mar 31, 2025 | 11.19 Mn |
| Mar 31, 2025 | 11.19 Mn |
| Dec 31, 2024 | 11.71 Mn |
| Dec 31, 2024 | 11.71 Mn |
| Sep 30, 2024 | 16.48 Mn |
| Sep 30, 2024 | 16.48 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Jun 30, 2024 | 8.54 Mn |
| Mar 31, 2024 | 8.54 Mn |
| Mar 31, 2024 | 8.54 Mn |
| Dec 31, 2023 | 8.57 Mn |
| Dec 31, 2023 | 8.57 Mn |